Ncic Clinical Trials Group
Clinical trials sponsored by Ncic Clinical Trials Group, explained in plain language.
-
New chemo combo trial aims to shrink aggressive breast tumors
Disease control CompletedThis study tested a combination of two chemotherapy drugs (epirubicin and docetaxel) along with a medication (pegfilgrastim) to help the immune system recover. It involved 93 women with locally advanced or inflammatory breast cancer who had not received prior cancer treatment. Th…
Phase: PHASE1, PHASE2 • Sponsor: NCIC Clinical Trials Group • Aim: Disease control
Last updated Apr 03, 2026 14:50 UTC
-
New drug cocktail battles advanced blood cancer
Disease control CompletedThis study tested a combination of five drugs as a first treatment for people with advanced follicular lymphoma, a type of blood cancer. The goal was to see how well the drug mix worked to control the cancer and to carefully track its side effects, especially nerve damage. It inv…
Phase: PHASE2 • Sponsor: NCIC Clinical Trials Group • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC